Design, synthesis and characterization of novel 6-amino-5-cyano-2-morpholinopyrimidine derivatives: cytotoxicity, DFT, molecular docking, ADMET and molecular simulation studies

Authors: Yadav, Taruna; Sharma, Nutan; Kaur, Navjot; Deokar, Rhushikesh C; G, Shreya; Srinivasa, Sudhanva M; Pal, Sudhir Kumar; Khandelwal, Keertika

Source journal: RSC advances (2026-11-16)

DOI: 10.1039/d6ra07731e

Abstract

In the present work, a novel series of twenty-one diversely substituted 6-amino-5-cyano-2-morpholinopyrimidine derivatives 8(a-u) were designed, synthesized, and comprehensively characterized by (1)H, (13)C, IR & HRMS data. All the compounds were screened for in vitro anticancer activity against the hepatocellular carcinoma HepG2cell lines using the MTT and Trypan Blue dye exclusion assays, and for haemocompatibility using a haemolytic assay on human erythrocytes. Among the series, compounds 8j and 8l emerged as the most biologically active candidates, displaying IC(50) values of 42.45 +/- 1.55 microM and 48.25 +/- 2.19 microM against HepG2 cells, respectively, while exhibiting selectivity indices favorable over the normal human embryonic kidney (HEK) cell line. Density functional theory (DFT) calculations at the B3LYP/6-31G* level were performed on all compounds to evaluate frontier molecular orbital energies (E (HOMO), E (LUMO)), the HOMO-LUMO energy gap, global chemical reactivity descriptors, and electrophilicity indices. Molecular docking studies of the two most potent compounds against four target proteins-PI3Kalpha (4L23), Akt1 (4DRH), mTOR kinase domain (4JT6), and mTOR complex (6BCX)-were conducted to rationalize the observed biological activity. Compound 8j displayed the highest docking score against the Akt1 receptor (4DRH; -9.7 kcal mol(-1)), and was subsequently subjected to a 100 ns molecular dynamics (MD) simulation, confirming the stability of the protein-ligand complex. In silico ADMET profiling revealed that all compounds comply with Lipinski's rule of five and exhibit favorable absorption, distribution, metabolism, and excretion properties. Collectively, these findings identify compound 8j as a promising lead scaffold for further optimization as an anticancer agent.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.